Basiliximab
| Drug Category | Drug | IHD Dosing | Administration Timing Around HD Session |
|---|---|---|---|
| Immunosuppressants | Basiliximab | Normal dose based on indication | Administer Anytime During HD |
Molecular Weight (Da) | Excreted Unchanged (%) | Normal Half-Life (Hours) | ESRD Half-Life (Hours) | Plasma Protein Binding (%) | Volume of Distribution (L/kg) | Dialytic Plasma Clearance (ml/min) | % Dialyzed |
|---|---|---|---|---|---|---|---|
| 143801 | N/A | 13 (days) | N/A | N/A | 0.12 (based on 70 kg) | N/A | N/A |
References:
- Bhorade S, Stern E. Immunosuppression for lung transplantation. Proceedings of the American Thoracic Society 2009; 6(1), 47-53.
- DrugBank [Online]. 2012 Apr 12 [cited 2012 May 6]; Available from: URL: http://www.drugbank.ca/drugs/DB00074